It will be interesting to see longer-term data to see the final plateau of weight loss. She adds that given the minimal data so far from the company, Amgen is sort of a wild card, as it could either be best-in-class or encounter issues with tolerability or safety that make it less compelling. Then there is Roche, which just this past week entered the fray with the acquisition of private biotechnology company Carmot, which has three clinical-stage obesity drugs in the works
The mechanism is straightforward: semaglutide slows gastric emptying and reduces stomach acid production, both of which impair dietary B12 absorption over time
Energy and mood typically remain stable
Rehwinkel, J
In reality, the world of peptides is broader than a single trending name, and the right approach depends on your body, your labs, and your goals
On provider involvement: Licensed providers on the platform are independent professionals who make their own medical judgments